"This article and the results of the soon-to-be-completed LipiGesic M children's study are significant milestones as we continue to build awareness within both the medical and consumer markets," said Mitchell.Currently, LipiGesic M is available at both Walgreens and CVS/pharmacy stores. One box of LipiGesic M typically treats four headaches at a cost of approximately $5 per treatment. About PuraMed BioScience ®, Inc.: PuraMed BioScience, Inc. engages in the research, development, and marketing of non-prescription medicinal and healthcare products. PuraMed has completed a double blind placebo clinical trial for its leading product, LipiGesic ®M, a sublingual acute treatment for the relief of migraine headaches, which was published in the top-tier medical journal, Headache: The Journal of Head and Face Pain. LipiGesic ®M has national distribution and is available nationwide in some of the largest chain drug stores in the United States. In addition to LipiGesic ® M, the Company also has plans to launch LipiGesic ® H for tension-type headaches as well as LipiGesic ® PM, which provides a remedy for insomnia and other sleep disorders. Forward-Looking Statements: This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events. Contact: PuraMed BioScience, Inc. Russell Mitchell, Chairman and CEO 715-359-6373 email@example.comProduct Website: www.lipigesic.comCorporate Website: www.puramedbioscience.com SOURCE PuraMed BioScience, Inc.